Alexander M Tatara, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 14 | 2023 | 1865 | 2.320 |
Why?
|
| Mandible | 5 | 2023 | 753 | 1.360 |
Why?
|
| Dermatomycoses | 2 | 2019 | 48 | 1.170 |
Why?
|
| Antifungal Agents | 6 | 2021 | 753 | 1.130 |
Why?
|
| Prosthesis-Related Infections | 3 | 2022 | 487 | 1.090 |
Why?
|
| Aspergillosis | 3 | 2019 | 242 | 1.050 |
Why?
|
| Bioreactors | 5 | 2020 | 246 | 0.970 |
Why?
|
| Mycobacterium marinum | 1 | 2024 | 29 | 0.940 |
Why?
|
| Drug Delivery Systems | 5 | 2020 | 2222 | 0.760 |
Why?
|
| Aspergillus fumigatus | 3 | 2019 | 157 | 0.760 |
Why?
|
| Bone Substitutes | 2 | 2019 | 236 | 0.680 |
Why?
|
| Wound Infection | 2 | 2019 | 244 | 0.660 |
Why?
|
| Mandibular Injuries | 1 | 2019 | 20 | 0.660 |
Why?
|
| Mycoses | 2 | 2021 | 386 | 0.630 |
Why?
|
| Econazole | 1 | 2018 | 4 | 0.630 |
Why?
|
| Periosteum | 1 | 2019 | 136 | 0.620 |
Why?
|
| Arthroplasty, Replacement | 1 | 2022 | 309 | 0.610 |
Why?
|
| Staphylococcus aureus | 3 | 2022 | 1457 | 0.600 |
Why?
|
| Biocompatible Materials | 4 | 2020 | 1683 | 0.600 |
Why?
|
| Staphylococcal Infections | 3 | 2022 | 1406 | 0.600 |
Why?
|
| Sheep | 7 | 2023 | 1436 | 0.580 |
Why?
|
| Glycols | 1 | 2017 | 55 | 0.580 |
Why?
|
| Succinates | 1 | 2017 | 81 | 0.570 |
Why?
|
| Fumarates | 1 | 2017 | 131 | 0.540 |
Why?
|
| Polyesters | 1 | 2017 | 371 | 0.500 |
Why?
|
| Tissue Scaffolds | 4 | 2017 | 932 | 0.490 |
Why?
|
| Bacteremia | 1 | 2022 | 977 | 0.480 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2022 | 1413 | 0.470 |
Why?
|
| Alendronate | 1 | 2014 | 175 | 0.420 |
Why?
|
| Polymethyl Methacrylate | 4 | 2018 | 132 | 0.420 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 858 | 0.400 |
Why?
|
| Regenerative Medicine | 1 | 2015 | 306 | 0.400 |
Why?
|
| Awards and Prizes | 1 | 2015 | 360 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 5 | 2024 | 7402 | 0.370 |
Why?
|
| Blood Platelets | 1 | 2022 | 2478 | 0.370 |
Why?
|
| Rotator Cuff | 1 | 2014 | 348 | 0.370 |
Why?
|
| Hospital Mortality | 1 | 2024 | 5293 | 0.360 |
Why?
|
| Bone Resorption | 1 | 2014 | 723 | 0.350 |
Why?
|
| X-Ray Microtomography | 4 | 2016 | 455 | 0.340 |
Why?
|
| Rhizopus | 2 | 2021 | 22 | 0.320 |
Why?
|
| Mucormycosis | 3 | 2020 | 103 | 0.300 |
Why?
|
| Surgical Flaps | 2 | 2023 | 1670 | 0.290 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 794 | 0.270 |
Why?
|
| Wound Healing | 1 | 2017 | 2802 | 0.270 |
Why?
|
| Orthopedic Procedures | 1 | 2016 | 1265 | 0.270 |
Why?
|
| Lymphangitis | 1 | 2024 | 15 | 0.240 |
Why?
|
| Societies, Medical | 1 | 2015 | 3900 | 0.220 |
Why?
|
| Porosity | 3 | 2020 | 348 | 0.210 |
Why?
|
| Larva | 2 | 2021 | 508 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.200 |
Why?
|
| Rifabutin | 1 | 2022 | 59 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.200 |
Why?
|
| Drug Users | 1 | 2022 | 134 | 0.180 |
Why?
|
| Transplantation, Autologous | 2 | 2016 | 2112 | 0.180 |
Why?
|
| Mucorales | 1 | 2020 | 35 | 0.180 |
Why?
|
| Hydrogels | 2 | 2016 | 720 | 0.180 |
Why?
|
| Pandemics | 1 | 2020 | 8645 | 0.170 |
Why?
|
| Calcineurin | 1 | 2020 | 229 | 0.160 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 18221 | 0.160 |
Why?
|
| Bone Transplantation | 2 | 2023 | 927 | 0.160 |
Why?
|
| Arthritis, Infectious | 1 | 2022 | 347 | 0.160 |
Why?
|
| Animals | 19 | 2023 | 168201 | 0.150 |
Why?
|
| Epidermal Growth Factor | 1 | 2021 | 699 | 0.150 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2017 | 18 | 0.150 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2022 | 529 | 0.150 |
Why?
|
| Wettability | 1 | 2017 | 27 | 0.150 |
Why?
|
| Mucous Membrane | 1 | 2021 | 659 | 0.150 |
Why?
|
| Polymers | 2 | 2015 | 1614 | 0.140 |
Why?
|
| Bone Regeneration | 1 | 2020 | 432 | 0.140 |
Why?
|
| Aspergillus | 1 | 2017 | 93 | 0.140 |
Why?
|
| Compressive Strength | 1 | 2017 | 158 | 0.140 |
Why?
|
| Bone Diseases | 1 | 2020 | 418 | 0.140 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2022 | 637 | 0.130 |
Why?
|
| Clindamycin | 1 | 2017 | 139 | 0.130 |
Why?
|
| Virulence | 2 | 2020 | 1299 | 0.130 |
Why?
|
| Facial Injuries | 1 | 2018 | 190 | 0.130 |
Why?
|
| Bone and Bones | 2 | 2018 | 2565 | 0.130 |
Why?
|
| Calcium Phosphates | 1 | 2016 | 171 | 0.130 |
Why?
|
| Cross Infection | 1 | 2024 | 1422 | 0.130 |
Why?
|
| Serum | 1 | 2016 | 208 | 0.120 |
Why?
|
| Candida albicans | 1 | 2018 | 372 | 0.120 |
Why?
|
| Stress, Mechanical | 1 | 2020 | 1674 | 0.120 |
Why?
|
| Spores, Fungal | 3 | 2021 | 90 | 0.120 |
Why?
|
| Host Specificity | 1 | 2015 | 57 | 0.120 |
Why?
|
| Molecular Weight | 1 | 2017 | 2185 | 0.120 |
Why?
|
| Skin Diseases, Infectious | 1 | 2015 | 76 | 0.120 |
Why?
|
| Acrylamides | 1 | 2016 | 259 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 745 | 0.120 |
Why?
|
| Viral Vaccines | 1 | 2020 | 595 | 0.120 |
Why?
|
| Materials Testing | 1 | 2018 | 862 | 0.120 |
Why?
|
| Anthraquinones | 1 | 2014 | 41 | 0.120 |
Why?
|
| Fluoresceins | 1 | 2014 | 235 | 0.110 |
Why?
|
| Cause of Death | 1 | 2024 | 3683 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 1333 | 0.110 |
Why?
|
| Models, Animal | 1 | 2020 | 2109 | 0.110 |
Why?
|
| Mandibular Neoplasms | 1 | 2014 | 130 | 0.110 |
Why?
|
| Zebrafish | 2 | 2021 | 3007 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 1454 | 0.110 |
Why?
|
| Femoral Fractures | 1 | 2017 | 375 | 0.110 |
Why?
|
| Humans | 22 | 2024 | 760617 | 0.100 |
Why?
|
| Epithelial Cells | 2 | 2021 | 3672 | 0.100 |
Why?
|
| Surgical Wound Infection | 1 | 2022 | 1529 | 0.100 |
Why?
|
| Gelatin | 1 | 2014 | 220 | 0.100 |
Why?
|
| Connective Tissue Diseases | 1 | 2015 | 285 | 0.100 |
Why?
|
| Prostheses and Implants | 2 | 2020 | 1269 | 0.100 |
Why?
|
| Triazoles | 1 | 2017 | 903 | 0.100 |
Why?
|
| Phosphates | 1 | 2015 | 769 | 0.100 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2022 | 1393 | 0.100 |
Why?
|
| Weight-Bearing | 1 | 2014 | 532 | 0.090 |
Why?
|
| Light | 1 | 2017 | 1352 | 0.090 |
Why?
|
| Osteomyelitis | 1 | 2015 | 407 | 0.090 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2014 | 238 | 0.090 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 591 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2014 | 962 | 0.090 |
Why?
|
| Osteoclasts | 1 | 2014 | 711 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6188 | 0.090 |
Why?
|
| Comorbidity | 1 | 2024 | 10505 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 2745 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2022 | 3045 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2015 | 1565 | 0.080 |
Why?
|
| Drug Carriers | 1 | 2014 | 706 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2014 | 2668 | 0.080 |
Why?
|
| Swine | 1 | 2018 | 5907 | 0.070 |
Why?
|
| Female | 11 | 2024 | 392148 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2015 | 2764 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2014 | 1270 | 0.070 |
Why?
|
| Nerve Growth Factors | 1 | 2009 | 564 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 58894 | 0.060 |
Why?
|
| Models, Biological | 2 | 2021 | 9461 | 0.060 |
Why?
|
| Middle Aged | 4 | 2024 | 220584 | 0.060 |
Why?
|
| Mice | 4 | 2019 | 81368 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2009 | 924 | 0.050 |
Why?
|
| Hyphae | 1 | 2021 | 52 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 1600 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3244 | 0.050 |
Why?
|
| Fusarium | 1 | 2020 | 51 | 0.040 |
Why?
|
| Risk Factors | 2 | 2024 | 74115 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2017 | 1936 | 0.040 |
Why?
|
| Rifampin | 1 | 2022 | 339 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 169042 | 0.040 |
Why?
|
| Amphotericin B | 1 | 2018 | 142 | 0.040 |
Why?
|
| Ergosterol | 1 | 2017 | 19 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2022 | 1415 | 0.040 |
Why?
|
| Drug Resistance, Fungal | 1 | 2017 | 75 | 0.040 |
Why?
|
| Stem Cells | 1 | 2009 | 3516 | 0.030 |
Why?
|
| Male | 5 | 2024 | 360358 | 0.030 |
Why?
|
| Diptera | 1 | 2016 | 50 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 26180 | 0.030 |
Why?
|
| Lovastatin | 1 | 2016 | 115 | 0.030 |
Why?
|
| Young Adult | 3 | 2018 | 59179 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 398 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2017 | 412 | 0.030 |
Why?
|
| Texas | 1 | 2016 | 403 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2017 | 64568 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2015 | 826 | 0.030 |
Why?
|
| Hydroxyapatites | 1 | 2014 | 73 | 0.030 |
Why?
|
| Infant | 1 | 2016 | 36152 | 0.030 |
Why?
|
| Silk | 1 | 2014 | 90 | 0.030 |
Why?
|
| Simvastatin | 1 | 2016 | 346 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 42188 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1835 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 2017 | 907 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2014 | 212 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 2018 | 816 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 860 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 6520 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 1712 | 0.020 |
Why?
|
| Cattle | 1 | 2016 | 3841 | 0.020 |
Why?
|
| Femur | 1 | 2017 | 1307 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2014 | 683 | 0.020 |
Why?
|
| Neurotrophin 3 | 1 | 2009 | 61 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1970 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2009 | 184 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2009 | 381 | 0.020 |
Why?
|
| Neutrophils | 1 | 2021 | 3763 | 0.020 |
Why?
|
| Child | 1 | 2016 | 80079 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 88234 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2009 | 329 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2014 | 1013 | 0.020 |
Why?
|
| Rats | 2 | 2017 | 23717 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 220969 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2022 | 41457 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2009 | 618 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 2114 | 0.020 |
Why?
|
| Fibrin | 1 | 2009 | 507 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 4242 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8516 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2017 | 1896 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2015 | 1642 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 12966 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16571 | 0.010 |
Why?
|
| Calcium | 1 | 2015 | 5717 | 0.010 |
Why?
|
| DNA | 1 | 2015 | 7196 | 0.010 |
Why?
|
| Cell Survival | 1 | 2009 | 5780 | 0.010 |
Why?
|
| Time Factors | 1 | 2021 | 39913 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2009 | 2978 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5672 | 0.010 |
Why?
|
| Graft Survival | 1 | 2009 | 3820 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2009 | 4408 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 80566 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 54360 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 11514 | 0.010 |
Why?
|
| Neurons | 1 | 2009 | 9438 | 0.010 |
Why?
|